Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02150967
Title A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

cholangiocarcinoma

Therapies

Infigratinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.